⌘K

Login Start Free

Home/Filings/4/0001171843-19-001392

4//SEC Filing

VOGT SUSAN L N 4

Accession 0001171843-19-001392

CIK 0000898437other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:36 PM ET

Size

4.9 KB

Accession

0001171843-19-001392

Insider Transaction Report

Form 4

Period: 2019-02-26

Anika Therapeutics, Inc.ANIK

Director

Transactions

Award
Common Stock
2019-02-26+3,842→ 7,545 total

Footnotes (1)

[F1]These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 26, 2020.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeother

Related Parties

1

filerCIK 0001191270

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 4:36 PM ET
Size: 4.9 KB

View on SEC.gov